A molecular basis for control of T cell memory
A molecular basis for control of T cell memory
批准号:
8970549
负责人:
STEPHEN M HEDRICK
金额:
$46.5万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-12-01 至 2017-11-30
关键词:
Acquired Immunodeficiency SyndromeAcuteAffectAntigensAppearanceB-LymphocytesBLR1 geneBackBinding SitesBioenergeticsBiological AssayBiologyCD4 Positive T LymphocytesCD8B1 geneCatabolismCell physiologyCellsCellular Metabolic ProcessChIP-seqCommunicable DiseasesCytomegalovirusCytotoxic T-Lymphocyte-Associated Protein 4Cytotoxic T-LymphocytesDNA RepairDataEnergy MetabolismEnhancersFamilyGene ExpressionGenesGeneticGenetic ModelsGrowthHIVHIV InfectionsHIV/HCVHealthHelper-Inducer T-LymphocyteHepatitis C virusHistonesHomeostasisImmuneImmune responseImmune systemImmunityImmunoglobulin Class SwitchingInfectionInfectious AgentInflammationInsulinInterleukin-7KnowledgeLymphocyteLymphocytic choriomeningitis virusMediatingMemoryMetabolicMetabolismMetforminMiningModelingMolecularMolecular BiologyMusMyeloid CellsNutrientObesityOutcomeOxidative StressOxygenPathway interactionsPatientsPhasePhenotypePhosphorylationPhysiologicalPlayPopulationPopulation AnalysisReactionRegulationRegulatory T-LymphocyteRoleSchemeSignal TransductionSirolimusStressStructure of germinal center of lymph nodeT cell differentiationT memory cellT-LymphocyteT-Lymphocyte SubsetsTestingTimeViralVirusVirus DiseasesVirus Replicationbasecell typedesignexhaustiongammaherpesviruslong term memorynext generation sequencingprecursor cellprogramsreceptorresearch studyresponsetranscription factor
中文摘要
描述(由申请人提供):急性和持续性病毒感染的进展部分取决于CD4和CD8 T细胞消除病毒感染细胞或有效阻止病毒复制的能力。这对于免疫系统从未清除的持久性病毒(例如 HIV、CMV 或 HCV)尤其重要。该提案描述了旨在了解指导 T 细胞分化和功能的中央控制机制的实验。 Foxo 转录因子受氧化应激、生长因子(如胰岛素)丰度、营养可用性或炎症等生理条件的差异调节。整合这些信息,它们促进或限制控制细胞生存、静止、DNA 修复和代谢的基因表达程序,并直接控制高度专业化的功能,包括:IL-7 受体、CTLA-4 和 Icos。特别是,初步数据表明 Foxo 转录因子控制感染后 CD8 细胞毒性 T 细胞的扩增和激活状态。此外,Foxo1 的缺失会促进 CD4 中央记忆前体细胞和能够产生 IL-21 的 CD4 滤泡辅助细胞的出现。这些结果与HIV精英控制者患者Foxo3活性缺陷的观察相结合,揭示了该转录因子模块对免疫系统产生的核心而深远的影响。我们建议对 Foxo1 和 Foxo3 转录因子在病毒感染的进展和清除中的作用进行深入分析,并对它们对基因表达编程的控制进行大规模分析。这些结果将对长期共同进化的病毒性疾病(例如艾滋病毒、疱疹和丙型肝炎病毒)的进展产生直接影响。
英文摘要
DESCRIPTION (provided by applicant): The progression of acute and persistent viral infections is governed, in part, by the ability of CD4 and CD8 T cells to eliminate virus-infected cells or effectively retard viral replication. This is especially important for persistent viruses uch as HIV, CMV, or HCV that are never cleared by the immune system. This proposal describes experiments designed to understand a central control mechanism guiding T cell differentiation and function. Foxo transcription factors are differentially regulated by physiological conditions such as oxidative stress, abundance of growth factors (such as insulin), nutrient availability, or inflammation. Integrating this information, they promote or restrict programs of gene expression that govern cellular survival, quiescence, DNA repair, and metabolism, and they directly control highly specialized functions including: the IL-7 receptor, CTLA-4, and Icos. In particular, preliminary data presented demonstrate that Foxo transcription factors control the expansion and activation status of CD8 cytotoxic T cells post-infection. In addition, the absence of Foxo1 promotes the appearance of CD4 central memory precursor cells, and CD4 follicular helper cells able to produce IL-21. These results combined with the observation that HIV elite controller patients have a deficit in Foxo3 activity, reveal the central and profound influence that this transcription factor module exerts on the immune system. We propose an in depth analysis of Foxo1 and Foxo3 transcription factors in the progression and clearance of virus infections, and a large-scale analysis of their control over the programming of gene expression. The results will have direct implications for the progression of long co-evolved viral diseases such as HIV, Herpes, and Hepatitis C virus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inflammation, Insulin Resistance, and Foxo factors
-
批准号:8607119
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2013
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Inflammation, Insulin Resistance, and Foxo factors
-
批准号:8431189
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2013
-
负责人:STEPHEN M HEDRICK
-
依托单位:
A molecular basis for control of T cell memory
-
批准号:8582538
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2012
-
负责人:STEPHEN M HEDRICK
-
依托单位:
A molecular basis for control of T cell memory
-
批准号:9184540
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2012
-
负责人:STEPHEN M HEDRICK
-
依托单位:
A molecular basis for control of T cell memory
-
批准号:8422783
-
项目类别:
-
资助金额:$43.71万
-
财政年份:2012
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Control of Lymphocyte Homeostasis by Foxo Transcription Factors
-
批准号:7529891
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2009
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Control of Lymphocyte Homeostasis by Foxo Transcription Factors
-
批准号:7842632
-
项目类别:
-
资助金额:$48.63万
-
财政年份:2009
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Training in Immunology
-
批准号:7123614
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2006
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Training in Immunology
-
批准号:7255513
-
项目类别:
-
资助金额:$21.77万
-
财政年份:2006
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Training in Immunology
-
批准号:7447908
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2006
-
负责人:STEPHEN M HEDRICK
-
依托单位:
CASPASE 8 AND AUTOPHAGY
-
批准号:7358114
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2006
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Training in Immunology
-
批准号:7870513
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2006
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Training in Immunology
-
批准号:7618029
-
项目类别:
-
资助金额:$24.33万
-
财政年份:2006
-
负责人:STEPHEN M HEDRICK
-
依托单位:
CASPASE 8 AND AUTOPHAGY
-
批准号:7181424
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2005
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Targeted antigens for novel strategies of vaccination
-
批准号:6805040
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2003
-
负责人:STEPHEN M HEDRICK
-
依托单位:
Targeted antigens for novel strategies of vaccination
-
批准号:6670806
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2003
-
负责人:STEPHEN M HEDRICK
-
依托单位:
CORE--TRANSGENIC MOUSE FACILITY
-
批准号:6653291
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2002
-
负责人:STEPHEN M HEDRICK
-
依托单位:
CANCER BIOLOGY
-
批准号:6653294
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2002
-
负责人:STEPHEN M HEDRICK
-
依托单位:
CANCER BIOLOGY
-
批准号:6592151
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2002
-
负责人:STEPHEN M HEDRICK
-
依托单位:
DRAK2, a kinase that regulates T cell activation
-
批准号:7148710
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2002
-
负责人:STEPHEN M HEDRICK
-
依托单位:
海外基金